Flyer

Health Science Journal

  • ISSN: 1791-809X
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Mohammed Sattar Abbas

MBCHB, Higher Diploma in Anaesthesia and Intensive Care Unit, Iraqi Ministry of Health, Baghdad, Iraq

Publications
  • Short Communication   
    Effect of Propofol, Midazolam on ICU patients with Sepsis
    Author(s): Mohammed Sattar Abbas*

    However, propofol and midazolam are widely used for intravenous sedation in very ill patients. Midazolam and propofol are used under light sedation in order to evaluate the effects of different sedation strategies on the clinical outcomes for sepsis patients. In a retrospective cross-sectional study between June 2021 and June 2023, an ICU in Baghdad Medical City examined sepsis patients who required mechanical ventilation and compared the sedation of those who got midazolam and propofol to those who did not. The outcomes of the sequential organ failure assessment (SOFA), day one acute physiology and chronic health evaluation II (APACHE II), and emergency surgery were all recorded for the patients. The midazolam and propofol groups each had 73 and 78 patients, with a mean age of 50 years (SD, 15.4 years) for the midazolam group and 56 years (SD, 16 years) for the propofol group, respec.. View More»

    Abstract HTML PDF